McAdam LLC Grows Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

McAdam LLC grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 29.1% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 980 shares of the healthcare conglomerate’s stock after buying an additional 221 shares during the quarter. McAdam LLC’s holdings in UnitedHealth Group were worth $496,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. Sutton Place Investors LLC lifted its position in shares of UnitedHealth Group by 5.2% during the fourth quarter. Sutton Place Investors LLC now owns 939 shares of the healthcare conglomerate’s stock worth $475,000 after purchasing an additional 46 shares in the last quarter. Jacobsen Capital Management lifted its holdings in UnitedHealth Group by 2.0% during the 4th quarter. Jacobsen Capital Management now owns 1,537 shares of the healthcare conglomerate’s stock worth $778,000 after buying an additional 30 shares in the last quarter. Greenleaf Trust grew its stake in shares of UnitedHealth Group by 1.1% in the fourth quarter. Greenleaf Trust now owns 23,242 shares of the healthcare conglomerate’s stock worth $11,757,000 after acquiring an additional 261 shares in the last quarter. Golden State Equity Partners boosted its holdings in UnitedHealth Group by 405.1% in the fourth quarter. Golden State Equity Partners now owns 3,359 shares of the healthcare conglomerate’s stock valued at $1,699,000 after purchasing an additional 2,694 shares during the period. Finally, Avantra Family Wealth Inc. purchased a new stake in UnitedHealth Group during the 4th quarter worth about $535,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Trading Down 0.6 %

Shares of UNH opened at $542.30 on Monday. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $630.73. The stock has a fifty day moving average of $536.17 and a two-hundred day moving average of $565.26. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The company has a market capitalization of $499.07 billion, a PE ratio of 34.99, a price-to-earnings-growth ratio of 1.48 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the company earned $5.83 EPS. As a group, analysts forecast that UnitedHealth Group Incorporated will post 29.63 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is 54.19%.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the stock. Piper Sandler cut their target price on shares of UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Wells Fargo & Company cut their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Stephens upped their price target on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, UBS Group lowered their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating on the stock in a report on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Buy” and a consensus target price of $629.32.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This represents a 28.57 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is owned by insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.